全文获取类型
收费全文 | 1902篇 |
免费 | 88篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 78篇 |
妇产科学 | 260篇 |
基础医学 | 226篇 |
口腔科学 | 29篇 |
临床医学 | 247篇 |
内科学 | 259篇 |
皮肤病学 | 42篇 |
神经病学 | 108篇 |
特种医学 | 15篇 |
外科学 | 152篇 |
综合类 | 97篇 |
一般理论 | 1篇 |
预防医学 | 299篇 |
眼科学 | 15篇 |
药学 | 67篇 |
中国医学 | 23篇 |
肿瘤学 | 76篇 |
出版年
2023年 | 23篇 |
2022年 | 41篇 |
2021年 | 50篇 |
2020年 | 76篇 |
2019年 | 286篇 |
2018年 | 318篇 |
2017年 | 152篇 |
2016年 | 38篇 |
2015年 | 46篇 |
2014年 | 94篇 |
2013年 | 111篇 |
2012年 | 57篇 |
2011年 | 102篇 |
2010年 | 68篇 |
2009年 | 72篇 |
2008年 | 86篇 |
2007年 | 58篇 |
2006年 | 51篇 |
2005年 | 52篇 |
2004年 | 43篇 |
2003年 | 26篇 |
2002年 | 28篇 |
2001年 | 16篇 |
2000年 | 16篇 |
1999年 | 9篇 |
1998年 | 4篇 |
1997年 | 11篇 |
1996年 | 8篇 |
1995年 | 6篇 |
1994年 | 4篇 |
1993年 | 3篇 |
1992年 | 5篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1985年 | 10篇 |
1984年 | 10篇 |
1983年 | 2篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有2002条查询结果,搜索用时 218 毫秒
1.
《台湾医志》2022,121(9):1864-1871
2.
3.
4.
Chu-Chih Chen Yin-Han Wang Wei J. Chen Chao A. Hsiung Yue-Liang Leon Guo Shu-Li Julie Wang 《International journal of hygiene and environmental health》2019,222(6):971-980
IntroductionPrenatal exposure to di(2-ethylhexyl) phthalate (DEHP) has been reported to be associated with adverse effects on neurodevelopment that yield behavior syndromes in young children with an estimated median exposure lower than the currently recommended tolerable daily intake (TDI) and reference dose (RfD).ObjectivesOur aim was to derive the benchmark dose for prenatal exposure to DEHP for the neurodevelopmental health in children.MethodsA total of 122 mother-child pairs from the Taiwan Maternal and Infant Cohort Study were analyzed for the dose-response relationship between maternal exposure to DEHP and children's behavioral syndromes evaluated at 8 years (n = 122, 2009), 11 years (n = 96, 2012), and 14 years (n = 78, 2015) of age. We employed a multivariate regression model to assess the statistical associations between the estimated maternal average daily intake of DEHP and child's individual CBCL scores for boys and girls at each separate age, followed by a mixed model for all the children across three ages accounting for individual variations. We then employed structural equation models by combining the children's specific behavioral problem scores at different ages and obtained a simulated overall latent score in relation to maternal exposure. Based on the established dose-response relationship, we derived the benchmark dose (BMD) and the lower limit (BMDL).ResultsAssociations of maternal DEHP exposure (median 4.54) with the Child Behavior Checklist (CBCL) scores were all significant, except for somatic complaints, adjusting for child's age, gender, IQ, and family income. The BMDL, given a benchmark response of 0.10 (0.05) and a background response of 0.05, was 6.01 (2.16) for an integrated CBCL score.ConclusionsThe current TDI (RfD) of 50 (20) for DEHP might not protect pregnant women for their children from behavioral problems. There remains the lack of comparable toxicological data. Further investigations are needed. 相似文献
5.
6.
7.
8.
Wei‐Hao Lin Hsing‐Chun Shih Sheng‐Yuan Wang Chuen‐Fu Lin Cheng‐Yao Yang Ming‐Tang Chiou Chao‐Nan Lin 《Transboundary and Emerging Diseases》2019,66(3):1138-1141
In March 2018, an abortion storm caused by porcine reproductive and respiratory syndrome virus was confirmed in a farrow‐to‐finish pig herd in Taiwan. Open reading frame 5 and non‐structural protein 2 of the virus confirmed that the virus is closely related to the virulent strains circulating in the United States. 相似文献
9.
Chih‐Hsiang Yu Wan‐Ting Chang Shiann‐Tarng Jou Tze‐Kang Lin Ya‐Hsuan Chang Chien‐Yu Lin Kai‐Hsin Lin Meng‐Yao Lu Shu‐Huey Chen Kang‐Hsi Wu Shih‐Chung Wang Hsiu‐Hao Chang Yi‐Ning Su Chia‐Cheng Hung Dong‐Tsamn Lin Hsuan‐Yu Chen Yung‐Li Yang 《Cancer science》2020,111(1):229-238
TP53 alterations are frequent relapse‐acquired mutations in childhood acute lymphoblastic leukemia (ALL). The present study evaluated the clinical significance of relapsed childhood ALL in Taiwan. Diagnostic and/or relapsed bone marrow or peripheral blood was obtained from 111 children with relapsed ALL who were initially treated by using Taiwan Pediatric Oncology Group (TPOG) ALL protocols from January 1997 to May 2018. Mutations were detected by PCR and sequencing, as well as by multiplex ligation‐dependent probe amplification to detect copy number alterations. Copy number and/or sequence alterations of TP53 were detected in 29% (28 of 98) and in 46% (6 of 13) of patients with relapsed B‐cell and T‐cell ALL, respectively. This incidence was much higher than that in several similar studies conducted in Caucasian populations. Seventy percent of all TP53 alterations were gained at relapse in 67 matched samples by back‐tracking matched diagnostic samples. TP53 alterations were associated with lower 5‐year event‐free survival (EFS) and overall survival (OS) rates (P = .013 and P = .0002, respectively). Multivariate analysis confirmed the prognostic significance of TP53 alterations. Forty‐five patients received hematopoietic stem‐cell transplantations post‐relapse. Patients with TP53 alterations (14/45) had inferior 5‐year EFS and OS than patients without TP53 alterations after transplantation (P = .002 and P = .001, respectively). The significance of these TP53 alterations for patients who received transplantations was confirmed by multivariate analysis. In conclusion, TP53 alterations were enriched and useful as prognostic markers in relapsed childhood ALL. 相似文献
10.